In this interview, we delve deep into the pioneering world of xenotransplantation and the evolving landscape of gene editing.
Normunity raises $75m to advance solid tumour targeting T-cell engagers – Pharmaceutical Technology
T-cell engagers are a class of immunotherapies that direct T cells to recognise and eliminate cancer cells. Credit: skynesher via Getty Images. US-based Normunity has
January 14, 2025